Clinical Trial Update: Placebo Controlled Trial of Bosentan in Scleroderma Patients [Phase 2]

View source ↗

Summary

A phase 2 placebo-controlled trial of bosentan in patients with systemic sclerosis and pulmonary hypertension was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Sclerosis

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Georgetown University | Conditions: Systemic Scleroderma, Pulmonary Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2011-07-20